Headquartered in Singapore, Inspius has helped 200+ tech companies here hire tech talent in Vietnam and bridged hundreds of great candidates to software engineering jobs that offer attractive compensation and great learning environments.
We’re an AI-driven digital therapy platform and wearables company enabling and empowering people for mobility and a better quality of life. It is focused on reducing the burden of musculoskeletal conditions, which affects about 25% of the world’s population.
Their 1st product, KIMIA Knee Recovery Management Solution, is the world’s 1st continuous monitoring device for the knee joint. It was initially launched in 2021 and has booked initial revenues from large implant companies and hospitals, currently deployed in some of the largest public hospitals in Singapore.
KIMIA is a proprietary sensing technology (based on >20 patents) which provides the world’s first continuous joint range of motion monitoring capability. The product was the National Winner and International Top 20 of the prestigious James Dyson Award 2020. Temasek Foundation recently funded Innomatch 2022, and it has gained traction with major public hospitals and orthopedic clinics. This product has recently received approval as a Class A medical device in Singapore.
The 2nd product of the company, KIMIA Home, is a digital therapist in the form of a mobile app capable of providing real-time exercise guidance and feedback using computer vision and AI and is currently being piloted with large corporate customers.
Round 1: Inspius screening:
Round 2: Client’s interview:
Total timeline: 2 weeks